We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-5.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$496M
AUM Growth
-$67M
Cap. Flow
-$12.4M
Cap. Flow %
-2.49%
Top 10 Hldgs %
25.38%
Holding
128
New
22
Increased
39
Reduced
44
Closed
16

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$7.57M
2
IRTC icon
iRhythm Holdings
IRTC
+$6.12M
3
TVTX icon
Travere Therapeutics
TVTX
+$5.83M
4
LNTH icon
Lantheus
LNTH
+$5.59M
5
ALKS icon
Alkermes
ALKS
+$5.45M

Top Sells

Rank Stock Value
1
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$12.4M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$8.48M
3
HCAT icon
Health Catalyst
HCAT
+$6.58M
4
TMO icon
Thermo Fisher Scientific
TMO
+$5.99M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$5.45M

Sector Composition

Rank Sector Weight
1 Healthcare 95.62%
2 Industrials 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
101
Neurocrine Biosciences
NBIX
$18.7B
$297K 0.06%
+3,050
New +$281K
RARE icon
102
Ultragenyx Pharmaceutical
RARE
$2.56B
$257K 0.05%
+4,300
New +$265K
SRPT icon
103
Sarepta Therapeutics
SRPT
$1.64B
$210K 0.04%
+2,800
New +$206K
GH icon
104
Guardant Health
GH
$20.2B
$192K 0.04%
4,770
– –
ASND icon
105
Ascendis Pharma A/S
ASND
$16.5B
$176K 0.04%
1,890
-4,239
-69% -$400K
IONS icon
106
Ionis Pharmaceuticals
IONS
$8.81B
$165K 0.03%
+4,450
New +$168K
MEDP icon
107
Medpace
MEDP
$16.1B
$159K 0.03%
+1,060
New +$153K
CRSP icon
108
CRISPR Therapeutics
CRSP
$4.77B
$151K 0.03%
2,490
-780
-24% -$45.9K
A icon
109
Agilent Technologies
A
$39.2B
$148K 0.03%
1,248
-2,552
-67% -$314K
VIR icon
110
Vir Biotechnology
VIR
$1.5B
$107K 0.02%
+4,200
New +$98.1K
NVCR icon
111
NovoCure
NVCR
$1.77B
$97K 0.02%
+1,400
New +$105K
FUSN
112
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$95K 0.02%
38,198
– –
AFMD
113
DELISTED
Affimed
AFMD
– –
-6,750
Closed -$295K
ALGN icon
114
Align Technology
ALGN
$12.4B
– –
-2,415
Closed -$1.05M
DXCM icon
115
DexCom
DXCM
$28.8B
– –
-28,000
Closed -$3.58M
EW icon
116
Edwards Lifesciences
EW
$50B
– –
-15,850
Closed -$1.87M
HCAT icon
117
Health Catalyst
HCAT
$154M
– –
-251,739
Closed -$6.58M
IOVA icon
118
Iovance Biotherapeutics
IOVA
$2.09B
– –
-222,000
Closed -$3.7M
OM icon
119
Outset Medical
OM
$88.1M
– –
-7,417
Closed -$5.05M
RPTX
120
DELISTED
Repare Therapeutics
RPTX
– –
-237,785
Closed -$3.39M
SGHT icon
121
Sight Sciences
SGHT
$286M
– –
-170,000
Closed -$1.97M
STVN icon
122
Stevanato
STVN
$5.51B
– –
-19,643
Closed -$395K
SYK icon
123
Stryker
SYK
$133B
– –
-6,950
Closed -$1.86M
PROC
124
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
– –
-109,245
Closed -$929K
BTTX
125
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
– –
-878,531
Closed -$1.74M
2 3 4
5
6

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sectoral Asset Management held 128 positions worth $496M, down 12% from $563M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sectoral Asset Management's Q2 2022 filing shows 22 new, 39 increased, 44 reduced and 16 closed positions. Its largest new stake was Travere Therapeutics: 232,000 shares worth $5.62M. The largest sale was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q2 2022 buy was Travere Therapeutics: 232,000 shares worth $5.62M.
  • Sectoral Asset Management added most to Icon in Q2 2022, an estimated $7.57M increase.
  • Sectoral Asset Management's biggest Q2 2022 reduction was Turning Point Therapeutics, Inc. Common Stock, cutting an estimated $8.48M.
  • Sectoral Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $12.4M.
  • Sectoral Asset Management's ten largest holdings make up 25% of its $496M portfolio in Q2 2022.
  • Sectoral Asset Management opened 22 new positions and closed 16 in Q2 2022.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $496M.

Based on Sectoral Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.